1. Home
  2. WSHP vs COCH Comparison

WSHP vs COCH Comparison

Compare WSHP & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WSHP

WeShop Holdings Limited Class A Ordinary Shares

HOLD

Current Price

$1.68

Market Cap

56.7M

Sector

N/A

ML Signal

HOLD

Logo Envoy Medical Inc.

COCH

Envoy Medical Inc.

HOLD

Current Price

$6.70

Market Cap

51.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
WSHP
COCH
Founded
2021
1995
Country
Jersey
United States
Employees
N/A
N/A
Industry
Blank Checks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
56.7M
51.3M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
WSHP
COCH
Price
$1.68
$6.70
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $19.67
AVG Volume (30 Days)
★ 65.3K
33.3K
Earning Date
11-24-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 17.45
EPS
★ N/A
N/A
Revenue
N/A
★ $241,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$15.33
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 7.11
52 Week Low
$1.67
$4.72
52 Week High
$225.00
$47.70

Technical Indicators

Market Signals
Indicator
WSHP
COCH
Relative Strength Index (RSI) 28.69 19.07
Support Level N/A $4.72
Resistance Level $2.82 $7.46
Average True Range (ATR) 0.31 0.41
MACD 0.03 0.93
Stochastic Oscillator 4.80 20.83

Price Performance

Historical Comparison
WSHP
COCH

About WSHP WeShop Holdings Limited Class A Ordinary Shares

WeShop Holdings Ltd is a community owned social commerce platform offering shoppers shares in the company every time customers make a purchase, recommend a product or refer a new member. WeShop earns revenues from advertising on their platform and commissions on the sales through the platform.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

Share on Social Networks: